Category Archives: pharma 4.0

Putting System Integrations in their Place: The Front End

Pharma system integration

System integration has been one of the most time-consuming, expensive, and risky aspects of implementing software solutions in pharmaceutical companies for years. Whether connecting a Quality Management System (QMS) to an Enterprise Resource Planning (ERP) platform or linking different parts of a Manufacturing system, the process has traditionally relied on complex, custom-built back-end integrations. These

Always Audit-Ready: How Automated Systems Transform Pharma Compliance

Preparing for an Audit

For young pharmaceutical companies, the prospect of an audit — whether internal or from regulators — can be intimidating. And it is not just the worries about the audit results; it is the large amount of preparation needed to get ready. Pulling together the proper documents, double-checking training records, and making sure every deviation is

Unlocking Growth in Brazil’s Pharma Market: Opportunities and Strategies for the Next Decade

Brazil Pharma Growth

Brazil represents one of the largest pharmaceutical markets in the world, ranking among the top ten globally and leading the Latin American region. Over the past decade, the sector has witnessed steady growth, driven by increasing healthcare investments, rising disposable incomes, and a growing middle class. As the world’s sixth-most populous country, Brazil offers a

Looking Ahead: The MENA Pharma Market is Poised for Continued, Dynamic Growth

MENA Pharma Market growth

The pharmaceutical market in the Middle East and North Africa (MENA) region is well positioned for significant growth over the next ten years. As the region matures, its regulatory frameworks will continue to strengthen, the market will expand, and local companies will increasingly compete on the global stage. This blog explores these trends, the factors

Emerging Market Dynamics in the MENA Pharma Space

Pharma 4

The pharmaceutical landscape in the Middle East and North Africa (MENA) region is undergoing a rapid transformation, and Saudi Arabia is firmly at its helm. With its proactive regulatory framework, ambitious Vision 2030 objectives, and substantial investment in local production, the Kingdom is shaping the future of the region’s pharma industry. Smart pharmaceutical companies and

Scigeniq Deepens Collaboration with ValGenesis; Becomes an Excellence Partner

Valgenesis Partner News

Dubai, UAE October 7, 2024: Scigeniq is pleased to announce it has evolved its partnership with ValGenesis from Service Partner to Excellence Partner, allowing it to take on a more active role in the sales, configuration, and implementation of ValGenesis’s flagship product, Validation Life Cycle Management Solution (“VLMS”). Scigeniq provides unique solutions that guide customers’

The Near-Term Impact of AI on Quality Systems and Software for Pharma

Impact of AI on Quality Systems and Software

As a software vendor providing quality and regulatory solutions to the pharmaceutical industry, Scigeniq is keenly aware of artificial intelligence’s (AI) transformative potential. The impact goes far beyond ChatGPT and its cousins’ generative capabilities; the impact on quality systems is much more focused on data-driven capabilities. We want to share how AI is shaping our

8 Takeaways from FCEPharma 2024

FCEPharma 2024

The Scigeniq team was present in force at the FCE Pharma conference earlier in June. The conference was huge and underscored the exciting trends and developments in the Latin American Pharma market. Focused on the Pharma Industry FCE Brazil is a major trade show and conference focused on the pharmaceutical industry. Held annually, the event

Look For Configurable Software in Pharma, Not Customized Software – Here’s Why

Configurable Software

If you are shopping for software, be careful what you ask for. If you ask for a custom feature or capability and the vendor says yes, it will probably end up being a bad thing. Trust me, I know. I have been in hundreds of those discussions over more than three decades – customization is

The MENA Pharma Market: Getting Ready for M&A Activity

Preparing for M&A Activity

With continued and accelerating growth, the Middle East and North Africa (MENA) region has become a major player in the global pharmaceutical market. Increasing demand for healthcare services and a growing population have driven strong growth, and a focus on local investment and development has accelerated the industry’s maturation. As the sector continues to mature,